Norges Bank
FMTX

Norges Bank’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Norges Bank’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8,003
Closed -$279K – 2215
2020
Q4 		$279K Hold
8,003
– – ﹤0.01% 2099
2020
Q3 		$399K Buy
+8,003
New +$323K ﹤0.01% 2094

Other funds holding FMTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Norges Bank's FMTX Position: Q1 2021 in Review

Norges Bank sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q1 2021, closing a stake of 8,003 shares — an estimated $279K sold.

Norges Bank first reported a position in FMTX in Q3 2020 and held it in 2 quarters. The position peaked at $399K in Q3 2020. 87 funds tracked by Wall St. Rank hold FMTX as of Q1 2021.

  • Norges Bank reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Norges Bank sold 8,003 Forma Therapeutics Holdings, Inc. Common Stock shares in Q1 2021, an estimated $279K.
  • Norges Bank first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2020 and held it in 2 quarters.
  • Norges Bank's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $399K in Q3 2020.
  • 87 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q1 2021.

Based on Norges Bank's 13F filing for Q1 2021, filed 7 May 2021.